Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo controlled, randomised clinical trial of efficacy and safety of cannabidiol (CBD)

BACKGROUND: Despite improvements in medical care, patients with advanced cancer still experience substantial symptom distress. There is increasing interest in the use of medicinal cannabinoids, but there is little high quality evidence to guide clinicians. This study aims to define the role of canna...

Descripción completa

Detalles Bibliográficos
Autores principales: Good, Phillip, Haywood, Alison, Gogna, Gauri, Martin, Jennifer, Yates, Patsy, Greer, Ristan, Hardy, Janet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898965/
https://www.ncbi.nlm.nih.gov/pubmed/31810437
http://dx.doi.org/10.1186/s12904-019-0494-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898965/
https://www.ncbi.nlm.nih.gov/pubmed/31810437
http://dx.doi.org/10.1186/s12904-019-0494-6

Ejemplares similares